Founded in 1946, Ilyang pharmaceutical is one of the leading Korean pharmaceutical companies that focus on developing new chemical entities (NCEs). It commensurate with its long experience, Ilyang pharmaceutical company has been kept its great reputation trying to cure patients. IL-YANG is now aim to become a global pharmaceutical company with NCE and expanding into the field of vaccination business and BIO medication.
We're tracking ILYANG's market expansion
How ILYANG's international expansion compares to its competitors
ILYANGYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 ILYANGYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Ilyang Pharma launched 'Bihem Iron Folic Acid Premium', a microencapsulated iron supplement with improved stability and absorption. It contains five functional ingredients for pregnant women and those needing iron supplements.
Daiso's health supplements were withdrawn after 5 days due to conflict with pharmacists. The Fair Trade Commission is investigating potential violations.
Korea Disease Control and Prevention Agency (KDCA) has signed procurement contracts for 12.07 million doses of influenza vaccine for the 2025-2026 season national vaccination program.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about ILYANG's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
